CEBPA and ovarian carcinoma: In summary, we show here for the first time that the c.690G>T SNP (rs34529039) in the CEBPA gene, along with CEBPA overexpression at the mRNA level, constitute factors of poor prediction and prognosis in ovarian cancer patients treated with DNA-damaging agents.